Autolus Therapeutics plc

NASDAQ:AUTL

Biotechnology

Healthcare
$1.06 +0.33%

+$0.01 today

Market cap
$282.13M
Beta
2.01
P/E (TTM)
-1.4
EPS (TTM)
-$1.09
52W Low $1.18High $2.70

Volume 2.56M

Average 1.60M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$283.57M

FY 2025 · Annual

Investing Cash Flow

$158.46M

FY 2025 · Annual

Financing Cash Flow

-$4.34M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(142.1M)(148.84M)(208.38M)(220.66M)(287.53M)
Depreciation & Amortization8.46M7.42M6.57M7.72M9.81M
Deferred Income Tax(72K)(268K)(986K)(185K)(286K)
Stock-Based Compensation9.94M12.01M11.2M15.47M14.44M
Change in Working Capital4.14M3.97M292K(23.66M)(52.11M)
Accounts Receivables0000(24.21M)
Inventory000(4.23M)(40.34M)
Accounts Payables(1.82M)22K(509K)1.59M1.3M
Other Working Capital5.95M3.95M801K(21.02M)11.14M
Other Non-Cash Items1.77M13.4M45.72M15.04M32.1M
Operating Cash Flow(117.86M)(112.31M)(145.59M)(206.27M)(283.57M)
Capital Expenditures(8.86M)(10.84M)(10.99M)(34.82M)(27.13M)
Acquisitions (Net)00000
Purchases of Investments000(359.73M)(242.62M)
Sales of Investments0000428.21M
Other Investing Activities000(12.74M)(8.09M)
Investing Cash Flow(8.86M)(10.84M)(10.99M)(394.55M)158.46M
Debt Repayment00000
Common Stock Issued245.9M163.85M0549.98M0
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities38.16M59.76M(883K)39.58M(4.34M)
Financing Cash Flow284.06M223.61M(883K)589.55M(4.34M)
Effect of Forex Changes(754K)(28.38M)15.03M(261K)6.28M
Net Change in Cash156.59M72.09M(142.43M)(11.53M)(123.17M)
Free Cash Flow(126.72M)(123.15M)(156.57M)(241.09M)(310.7M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$287.5M
+ D&A$9.8M
+ Stock-Based Comp$14.4M
- Deferred Tax-$286.0K
- Working Capital-$52.1M
+ Other Non-Cash$32.1M
= Operating Cash Flow-$283.6M
- Capex-$27.1M
= Free Cash Flow-$310.7M

Analysis

FY2025 free cash flow is -$310.7M. FCF conversion is 108.1% of net income. Operating cash flow was -$283.6M, with capex of -$27.1M. The largest bridge item is Working Capital at -$52.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 12, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13D/ASC 13D/A filingNov 10, 2026

Does AUTL generate free cash flow?

Autolus Therapeutics plc (AUTL) generated -$310.70M of free cash flow in fiscal 2025.

How much operating cash flow does AUTL produce?

Operating cash flow was -$283.57M, before capital expenditures of $27.13M.